PMA P100024S007

Device
HER2 CISH PHARMDX KIT
Applicant
Dako Denmark A/S
PMA number
P100024
Supplement
S007
Product code
NYQ
Decision date
2015-09-10
Generic name
Chromogenic in situ hybridization, nucleic acid amplification, HER2/NEU gene, breast cancer
Approval order statement
ALTERNATE WAREHOUSE ESTABLISHED WITHIN THE CURRENT FACILITY. THE CHANGE IS BEING MADE FOR THE STORAGE OF FINISHED DEVICES AFTER THEY HAVE BEEN QA RELEASED.

Current openFDA PMA Record#

Device
HER2 CISH PHARMDX KIT
Applicant
Dako Denmark A/S
PMA number
P100024
Supplement
S007
Product code
NYQ
Generic name
Chromogenic in situ hybridization, nucleic acid amplification, HER2/NEU gene, breast cancer
Decision date
2015-09-10
Decision code
OK30
Date received
2015-08-13
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
ALTERNATE WAREHOUSE ESTABLISHED WITHIN THE CURRENT FACILITY. THE CHANGE IS BEING MADE FOR THE STORAGE OF FINISHED DEVICES AFTER THEY HAVE BEEN QA RELEASED.